Zhang H, Fang Z. A novel glutathione-triggered theranostic prodrug for anticancer and imaging in living cells.
RSC Adv 2018;
8:11419-11423. [PMID:
35542771 PMCID:
PMC9079131 DOI:
10.1039/c8ra00271a]
[Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2018] [Accepted: 03/07/2018] [Indexed: 01/12/2023] Open
Abstract
A novel theranostic prodrug was designed and synthesized by conjugating a naphthalimide derivative with vitamin D2via a disulfide linker. The prodrug featured a highly selective detection process for glutathione (GSH) and showed a red-shifted fluorescence within 30 min. Notably, it also exhibited antitumor activity similar to vitamin D2 and could be monitored by cellular imaging.
A novel glutathione-triggered theranostic prodrug was synthesized by conjugating the naphthalimide chromophore and vitamin D2via a disulfide bond.![]()
Collapse